S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
AMZN   1,777.43 (+0.57%)
GE   8.91 (+0.11%)
TSLA   259.75 (+0.72%)
ACB   3.59 (-4.52%)
NFLX   286.28 (+0.71%)
BAC   30.18 (+1.51%)
S&P 500   2,989.69 (-0.20%)
DOW   27,001.98 (-0.08%)
QQQ   193.04 (-0.25%)
AAPL   234.37 (-0.40%)
FB   189.55 (+0.35%)
AMZN   1,777.43 (+0.57%)
GE   8.91 (+0.11%)
TSLA   259.75 (+0.72%)
ACB   3.59 (-4.52%)
NFLX   286.28 (+0.71%)
BAC   30.18 (+1.51%)
Log in

Processa Pharmaceuticals Stock Price, News & Analysis (OTCMKTS:PCSA)

$2.50
0.00 (0.00 %)
(As of 10/16/2019 04:00 PM ET)
Today's Range
$2.02
Now: $2.50
$2.50
50-Day Range
$2.43
MA: $2.54
$2.75
52-Week Range
$1.50
Now: $2.50
$4.40
Volume1,400 shs
Average Volume150 shs
Market Capitalization$97 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.38
Processa Pharmaceuticals, Inc., a pharmaceutical company, engages in the clinical development of drug products for the unmet medical needs. Its lead product candidate is PCS-499, an oral tablet for the treatment of necrobiosis lipoidica and radiation-induced fibrosis in head and neck cancer patients. The company is based in Hanover, Maryland.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PCSA
Previous SymbolOTCMKTS:HUWX
CUSIPN/A
CIKN/A
Phone443-776-3133

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.25 per share

Profitability

Net Income$-3,770,000.00

Miscellaneous

Employees15
Market Cap$97 million
Next Earnings Date11/12/2019 (Estimated)
OptionableNot Optionable

Receive PCSA News and Ratings via Email

Sign-up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter.


Processa Pharmaceuticals (OTCMKTS:PCSA) Frequently Asked Questions

What is Processa Pharmaceuticals' stock symbol?

Processa Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PCSA."

How were Processa Pharmaceuticals' earnings last quarter?

Processa Pharmaceuticals Inc (OTCMKTS:PCSA) announced its quarterly earnings data on Wednesday, August, 14th. The company reported ($0.03) earnings per share (EPS) for the quarter. View Processa Pharmaceuticals' Earnings History.

When is Processa Pharmaceuticals' next earnings date?

Processa Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Processa Pharmaceuticals.

Has Processa Pharmaceuticals been receiving favorable news coverage?

Media headlines about PCSA stock have trended positive on Wednesday, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Processa Pharmaceuticals earned a daily sentiment score of 2.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Processa Pharmaceuticals.

Who are some of Processa Pharmaceuticals' key competitors?

Who are Processa Pharmaceuticals' key executives?

Processa Pharmaceuticals' management team includes the folowing people:
  • Dr. David Young, Co- Founder, Chairman & CEO (Age 66)
  • Mr. Patrick Lin, Co-Founder, Chief Bus. & Strategy Officer and Director (Age 54)
  • Dr. Sian E. Bigora, Co-Founder & Chief Devel. Officer (Age 59)
  • Ms. Wendy Guy, Co-Founder & Chief Admin. Officer (Age 55)
  • Mr. James H. Stanker, Chief Financial Officer (Age 61)

How do I buy shares of Processa Pharmaceuticals?

Shares of PCSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Processa Pharmaceuticals' stock price today?

One share of PCSA stock can currently be purchased for approximately $2.50.

How big of a company is Processa Pharmaceuticals?

Processa Pharmaceuticals has a market capitalization of $97 million. Processa Pharmaceuticals employs 15 workers across the globe.View Additional Information About Processa Pharmaceuticals.

What is Processa Pharmaceuticals' official website?

The official website for Processa Pharmaceuticals is http://www.processapharmaceuticals.com/.

How can I contact Processa Pharmaceuticals?

Processa Pharmaceuticals' mailing address is 7380 COCA COLA DRIVE SUITE 106, HANOVER MD, 21076. The company can be reached via phone at 443-776-3133 or via email at [email protected]


MarketBeat Community Rating for Processa Pharmaceuticals (OTCMKTS PCSA)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  54 (Vote Underperform)
Total Votes:  111
MarketBeat's community ratings are surveys of what our community members think about Processa Pharmaceuticals and other stocks. Vote "Outperform" if you believe PCSA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PCSA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: FAANG Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel